Benefit of Cardiopoietic Mesenchymal Stem Cell Therapy on Left Ventricular Remodelling: Results From the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) Study
European Journal of Heart Failure - United States
doi 10.1002/ejhf.898
Full Text
Open PDFAbstract
Available in full text
Date
May 31, 2017
Authors
Publisher
Wiley